Wimberger P, Gerber MJ, Pfisterer J, Erdmann K, et al. Bevacizumab may differentially improve prognosis of advanced ovarian cancer patients with low expression of VEGF-A165b, an anti-angiogenic VEGF-A splice variant. Clin Cancer Res 2022 Aug 24. pii: 708584. doi: 10.1158/1078-0432.CCR-22-1326.
PMID: 36001383